Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2014-07-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
NCT06120400
Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults
NCT02364570
An Egg Based Breakfast Maintains Flexibility in Older Adults
NCT03164200
Assessment of Optimal Egg Intake in a Healthy Population
NCT02531958
Egg Intake, Metabolic Outcomes and Choline Levels
NCT06687122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eggs - 2 per day for breakfast
Participants will consume 2 eggs per day for breakfast for 4 weeks of the study.
Eggs - 2 per day for breakfast
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
1 packet of oatmeal per day
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
Oatmeal - 1 packet per day for breakfast
Participants will consume 1 packet of oatmeal per day for breakfast for 4 weeks of the study.
Eggs - 2 per day for breakfast
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
1 packet of oatmeal per day
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eggs - 2 per day for breakfast
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
1 packet of oatmeal per day
11-week crossover study in which participants consumed 2 eggs or 1 packet of oatmeal per day daily for 4 weeks, separated by a 3-week washout period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Currently taking glucose lowering drugs or supplements
* Plasma triglycerides \>500 mg/dL, glucose \>126, total cholesterol \>240
* Pregnant, lactating, or have endocrine or metabolic disorders
* BMI ≥ 30
* Blood pressure \> 140/90 (average of 3 readings)
* Allergies to eggs
* Celiac disease or gluten sensitivity
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Connecticut
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Luz Fernandez
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Connecticut
Storrs, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H14-032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.